FIB-4 INDEX IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: A CASE-CONTROL STUDY
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · 12.08.2026 · 28 (2) · 341-350
DOI: 10.24938/kutfd.1955821 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, online erschienen am 12.08.2026. Verfasst von Çağatay Emir Önder und 2 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Objective
Although the target organs for primary hyperparathyroidism (PHPT) are the renal and skeletal systems, hyperparathyroidism has also been linked with metabolic syndrome as well as non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate metabolic parameters, and the fibrosis-4 index (FIB-4) among patients with PHPT. Material and Methods: This study included 30 patients with PHPT and 30 healthy controls. FIB-4 index was calculated for all participants whose metabolic parameters were recorded. In addition, according to the FIB-4 index, participants were divided into low and medium-high risk categories for fibrosis using a cut-off value of 1.3. The participants’ metabolic parameters and the FIB-4 indices were compared.
Results
PHPT patients had a median age of 58 years (25–65), and 90% of them were female. Metabolic parameters (fasting plasma glucose, homeostasis model assessment of insulin resistance [HOMA-IR], and lipid parameters) did not vary across the groups (p>0.05). The PHPT group had a FIB-4 index value of 0.99 (0.36–1.51), and the control group 0.66 (0.41– 1.57) (p=0.030). The number of patients in the medium-high risk category was higher in the PHPT group than in the control group (p=0.040).
Conclusion
PHPT patients showed higher FIB-4 index values and a greater frequency of medium-to-high non-invasive fibrosis risk than controls. However, as FIB-4 is an indirect surrogate marker, these findings should not be interpreted as confirmed hepatic fibrosis. Further prospective studies using direct or imaging-based methods are warranted.
Zitieren
APA
Önder, Ç. E., Gökbulut, P., & Taşkaldıran, I. (2026). FIB-4 INDEX IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: A CASE-CONTROL STUDY. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, 28(2), 341-350. https://doi.org/10.24938/kutfd.1955821
Vancouver
Önder ÇE, Gökbulut P, Taşkaldıran I. FIB-4 INDEX IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: A CASE-CONTROL STUDY. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi. 2026;28(2):341-350. doi:10.24938/kutfd.1955821
BibTeX
@article{nder2026,
author = {Önder, Çağatay Emir and Gökbulut, Püren and Taşkaldıran, Işılay},
title = {FIB-4 INDEX IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: A CASE-CONTROL STUDY},
journal = {Kırıkkale Üniversitesi Tıp Fakültesi Dergisi},
year = {2026},
volume = {28},
number = {2},
pages = {341--350},
doi = {10.24938/kutfd.1955821}
}
EUVIMED